Guided by the "market- andcustomer-oriented " principle, the Pharscin Pharma remains committed to special, sophisticated, unique and novel features, purposely building a"dumbbell-shaped" modern pharmaceutical enterprise. Pharscin Pharma seeks to replace backward treatment with the combination of independent innovation and technical transformation, focusing on the prevention and treatment of commonand frequently-occurred diseases, like CNS, digestion, otolaryngology, oncology and cardiovascular and cerebrovascular related diseases.Currently, it has 68 drug approvals, including 49 drugs in the national "medical insurance" catalog, 46 drugs with domestic patents and one with the international patent.